Warning letter
Ladd Family Pharmacy LLC: warning letter of Sep 26, 2017
FDA warning letter 516046 · Los Angeles District Office
Key facts
| Reference number | 516046 |
|---|---|
| Company | Ladd Family Pharmacy LLC |
| Subject | Compounding Pharmacy/Adulteration/Misbranding |
| Issue date | Sep 26, 2017 |
| Posted date | Oct 10, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211.165(a), 200.10(b), 211.67(a), 211.166(a), 210.1(b) |
| Inspection city | Boise |
| Inspection ZIP | 83706 |
| Inspection start date | Sep 12, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: